Ravindranath Sanganabasappa Bilachi

6PUBLICATIONS
5CO-AUTHORS
Molecular targetsMetabolic medicinePredictive and prognostic markersBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 17, 2026
Multi-omics analysis positions DNA2 at the interface of genome integrity programs and tumor behavior in pan-cancer.

|Nov 25, 2025
Macrophage Phenotypic Switch and Obesity-Associated Metabolic Risk: Mechanisms and Targets.

K F Hinojosa Vera, C Hemakumar, R S Bilachi

|Jul 23, 2025
Prioritization of phytochemical isolation and characterization against HER2 as a breast cancer target based on chromatographic methods, DFT studies, 3D-QSAR analysis, and molecular docking simulations.

B S Lakshmi, Jayanna K Bidarur, H G Anilkumar

|Jul 14, 2025
PCNA in Pan-Cancer: A Prognostic Biomarker Unveiled Through a Data-Driven, Multidimensional Analysis of Transcriptomics, Immunity, and Functional Profiling.

Depanshi Pandit, Ravindranath Bilachi Sanganabasappa, Amardeep Dhillon

|Jan 16, 2023
Marmesin and Marmelosin Interact with the Heparan Sulfatase-2 Active Site: Potential Mechanism for Phytochemicals from Bael Fruit Extract as Antitumor Therapeutics.

C Hemakumar, B S Ravindranath, G A Ravishankar

|May 25, 2021
RNR inhibitor binding studies of <i>Chlamydia felis</i>: insights from <i>in silico</i> molecular modeling, docking, and simulation studies.

B S Ravindranath, S Vishnu Vinayak, Vivek Chandra Mohan

Pageof 1

Frequent Collaborators

2 joint publications

C Hemakumar

2 joint publications

D C Ramirez

1 joint publications

G A Ravishankar

1 joint publications

S V Kiran